BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological activities of a phosphorodithioate analog of 2',5'-oligoadenylate. 1995

L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Department of Chemistry and Biochemistry, Ribozyme Pharmaceuticals Inc., Boulder, CO 80301, USA.

To enhance the resistance of 2-5A (pppA2'p5'A2'p5'A) to degradation by exo- and endonucleases, a phosphorodithioate analog was synthesized using a solid-phase phosphite triester approach with N6-benzoyl-5'-O-dimethoxytrityl-3'-O-t-butyldimethylsilyladenosine 2'-[S-(beta-thiobenzoylethyl)-pyrrolidinophosphorothioamidit e]. 5'-Monophosphorylation was accomplished with 2-[2-(4,4'-dimethoxytrityloxy)-ethylsulfonyl]ethyl-(2-cyanoe thyl)-(N,N- diisopropyl)-phosphoramidite. The resulting product, p5'A2'(s2p)- 5'A2'(s2p)5'A, was approximately 10-fold less effective as an activator of purified human recombinant 2-5A-dependent RNase than was 2-5A itself. This loss of activation ability was related directly to the loss of binding ability of the phosphorodiothioate analog. As predicted, p5'A2'(s2p)5'A2' (s2p)5'A was stable to snake venom phosphodiesterase and the nucleolytic activities of both human lymphoblastoid CEM cell extracts and human serum, under conditions that led to facile degradation of parent 2-5A. This nuclease stability permitted the observation of the CEM cell extracts and human serum phosphatase activity which led to 5'-dephosphorylation of p5'A2'(s2p)5'A2'(s2p)5'A.

UI MeSH Term Description Entries
D009843 Oligoribonucleotides A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004720 Endonucleases Enzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains. EC 3.1.-. Endonuclease
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005092 Exonucleases Enzymes that catalyze the release of mononucleotides by the hydrolysis of the terminal bond of deoxyribonucleotide or ribonucleotide chains. Exonuclease,3'-5'-Exonuclease,3'-5'-Exonucleases,5'-3'-Exonuclease,5'-3'-Exonucleases,3' 5' Exonuclease,3' 5' Exonucleases,5' 3' Exonuclease,5' 3' Exonucleases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000227 Adenine Nucleotides Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Synthesis and biological activities of beta-alanyltyrosine derivative of 2',5'-oligoadenylate, and its use in radiobinding assay for 2',5-oligoadenylate.
February 1987, Journal of biochemistry,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatic synthesis, properties, and biological activities of 2',5'-phosphorothioates from adenosine 5'-O-(2-thiotriphosphate) and adenosine 5'-O-(3-thiotriphosphate).
November 1987, Biochemistry,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Chemical synthesis of 2',5'-oligoadenylate analogues.
January 1994, Progress in molecular and subcellular biology,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
2',5'-Oligoadenylate and 2',5'-oligoadenylate phosphodiesterase in human plasma.
December 1984, Biochemical and biophysical research communications,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Heterogeneous nuclear RNA promotes synthesis of (2',5')oligoadenylate and is cleaved by the (2',5')oligoadenylate-activated endoribonuclease.
February 1982, Molecular and cellular biology,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Synthesis, characterisation and biological significance of (2'-5')oligoadenylate derivatives of NAD+, ADP-ribose and adenosine(5')tetraphospho(5')adenosine.
March 1982, European journal of biochemistry,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Synthesis and biological activities of novel 5-(2-acylethynyl)uracils.
July 1990, Journal of medicinal chemistry,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Synthesis and biological activity of 2',5'-oligoadenylate trimers containing 5'-terminal 5'-amino-5'-deoxy- and 5'-amino-3',5'-dideoxyadenosine derivatives.
January 1999, Nucleosides & nucleotides,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
Synthesis and biological activities of a fluorescent photoaffinity analog of vasopressin.
July 1985, Endocrinology,
L Beigelman, and J Matulic-Adamic, and P Haeberli, and N Usman, and B Dong, and R H Silverman, and S Khamnei, and P F Torrence
[Interferon-induced 2',5'-oligoadenylate system: key components and biological functions].
January 2003, Ukrains'kyi biokhimichnyi zhurnal (1999 ),
Copied contents to your clipboard!